Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hexal a/s - metoprololum súkkínat - forðatafla - 100 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hexal a/s - metoprololum súkkínat - forðatafla - 25 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hexal a/s - metoprololum súkkínat - forðatafla - 50 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - melatoninum inn; sucralose - mixtúra, lausn - 1 mg/ml

Evrópusambandið - íslenska - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamíð - blöðruhálskirtli - innkirtla meðferð - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - merópenemi trihydrate, vaborbactam - urinary tract infections; bacteremia; bacterial infections; respiratory tract infections; pneumonia; pneumonia, ventilator-associated - sýklalyf fyrir almenn nota, - vaborem er ætlað fyrir meðferð eftirfarandi sýkingum í fullorðnir:flókið þvagfærasýkingu (cuti), þar á meðal pyelonephritiscomplicated kviðarholi sýkingu (ciai)sjúkrahús-keypti lungnabólgu (gerst), þar á meðal öndunarvél tengslum lungnabólgu (ho chi minh city). meðferð sjúklinga með bacteraemia sem á sér stað í tengslum við, eða er grunaður að vera í tengslum við, allir sýkingar að ofan. vaborem er einnig ætlað til meðferð sýkingum vegna úti gramm-neikvæð lífvera í fullorðnir með takmarkaða meðferð valkosti. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - Æxlishemjandi lyf - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 50 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 25 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - sodium chloride; kalii chloridum; magnesii chloridum; sodium acetate trihydrate; natrii gluconas - innrennslislyf, lausn